Shares of Glenmark Pharmaceuticals rose over 2 percent to a 52-week high of Rs 512.65 on Monday morning following its agreement with Forest Laboratories on a collaboration for development of inhibitors to treat chronic inflammatory conditions, including pain.
first published: Dec 24, 2012 10:09 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

